- Home
- WK vs RYTM Comparison
WK vs RYTM Comparison
Compare WK & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WK
- RYTM
- Stock Information
- Founded
- WK 2008
- RYTM 2008
- Country
- WK United States
- RYTM United States
- Employees
- WK N/A
- RYTM N/A
- Industry
- WK Computer Software: Prepackaged Software
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- WK Technology
- RYTM Health Care
- Exchange
- WK Nasdaq
- RYTM Nasdaq
- Market Cap
- WK 4.0B
- RYTM 4.3B
- IPO Year
- WK 2014
- RYTM 2017
- Fundamental
- Price
- WK $65.41
- RYTM $61.99
- Analyst Decision
- WK Strong Buy
- RYTM Strong Buy
- Analyst Count
- WK 9
- RYTM 12
- Target Price
- WK $107.00
- RYTM $76.75
- AVG Volume (30 Days)
- WK 436.6K
- RYTM 525.0K
- Earning Date
- WK 07-31-2025
- RYTM 08-05-2025
- Dividend Yield
- WK N/A
- RYTM N/A
- EPS Growth
- WK N/A
- RYTM N/A
- EPS
- WK N/A
- RYTM N/A
- Revenue
- WK $769,293,000.00
- RYTM $136,863,000.00
- Revenue This Year
- WK $20.80
- RYTM $37.56
- Revenue Next Year
- WK $16.33
- RYTM $74.99
- P/E Ratio
- WK N/A
- RYTM N/A
- Revenue Growth
- WK 17.36
- RYTM 48.88
- 52 Week Low
- WK $60.50
- RYTM $39.46
- 52 Week High
- WK $116.83
- RYTM $69.89
- Technical
- Relative Strength Index (RSI)
- WK 39.02
- RYTM 47.67
- Support Level
- WK $65.62
- RYTM $60.70
- Resistance Level
- WK $68.08
- RYTM $62.65
- Average True Range (ATR)
- WK 1.68
- RYTM 2.39
- MACD
- WK -0.09
- RYTM -0.52
- Stochastic Oscillator
- WK 8.14
- RYTM 14.04
About WK Workiva Inc.
Workiva Inc is a cloud-native platform that simplifies the complexities of reporting and compliance. Workiva platform empowers customers by connecting and transforming data from hundreds of enterprise resource planning (ERP), human capital management (HCM), and customer relationship management (CRM) systems, as well as other third-party cloud and on-premise applications. Customers use the platform to create, review and publish data-linked documents and reports with greater control, consistency, accuracy, and productivity and it is also used for SEC Filings. Company's Geographical region consist of USA, Netherland, UK, and Others. Majority of revenue is from USA.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.